Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003131
Filing Date
2025-03-17
Accepted
2025-03-17 16:45:58
Documents
139
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xoma-20241231x10k.htm   iXBRL 10-K 4016383
2 EX-4.10 xoma-20241231xex4d10.htm EX-4.10 103146
3 EX-10.30 xoma-20241231xex10d30.htm EX-10.30 17907
4 EX-10.34 xoma-20241231xex10d34.htm EX-10.34 51442
5 EX-19.1 xoma-20241231xex19d1.htm EX-19.1 50581
6 EX-21.1 xoma-20241231xex21d1.htm EX-21.1 6827
7 EX-23.1 xoma-20241231xex23d1.htm EX-23.1 3627
8 EX-31.1 xoma-20241231xex31d1.htm EX-31.1 10730
9 EX-31.2 xoma-20241231xex31d2.htm EX-31.2 10751
10 EX-32.1 xoma-20241231xex32d1.htm EX-32.1 8216
  Complete submission text file 0001558370-25-003131.txt   18264894

Data Files

Seq Description Document Type Size
11 EX-101.SCH xoma-20241231.xsd EX-101.SCH 142726
12 EX-101.CAL xoma-20241231_cal.xml EX-101.CAL 104811
13 EX-101.DEF xoma-20241231_def.xml EX-101.DEF 717109
14 EX-101.LAB xoma-20241231_lab.xml EX-101.LAB 1033340
15 EX-101.PRE xoma-20241231_pre.xml EX-101.PRE 1009721
142 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20241231x10k_htm.xml XML 3133288
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39801 | Film No.: 25745237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)